Literature DB >> 33068239

The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.

Mikiyas Amare Getu1, Changying Chen2, Wang Panpan3, Joanes Faustine Mboineki3, Kamala Dhakal3, Ruofei Du3.   

Abstract

PURPOSE: Several lines of clinical research support the efficacy of Cognitive behavioral therapy (CBT) with a large number of population and various disease conditions, however, the true effects of CBT interventions on Quality of Life of breast cancer patients remain unknown. The aim of the study was to evaluate the effect of Cognitive Behavioral Therapy on the Quality of Life of breast cancer patients.
METHODS: A systematic review of articles published using Web of Science (1950-January 2020); Medline via EBSCO (1992-January 2020); Science direct via ELSEVIER (1996-January 2020); SCOPUS (2004-January 2020); and PubMed (1946-January 2020 excluding Medline from 1992-January 2020) were included. Additional studies were included after  checking reference lists of all relevant studies; searching ongoing trials and research registers and manual search. Data extraction was conducted by two independent authors and a third independent author checked the data extraction. The PRISMA statement was adopted. RESULT: Eleven Randomized controlled trials (RCT) with 1690 breast cancer patients were included in this review. The overall effect size of cognitive behavioral therapy on QoL of breast cancer patients was medium 0.39 (95% CI 0.12-0.66, P < 0.00001, I2 = 83%). Five studies had shown statistically significant improvement in functional and symptoms scales in the treatment group than the control group.
CONCLUSION: CBT is effective in improving the Quality of Life of breast cancer patients. In future research, further randomized controlled trials with adequate randomization, allocation concealment, and appropriate blinding may be needed.

Entities:  

Keywords:  Breast cancer; Cognitive behavioral therapy; Quality of life; Randomized controlled trial; Systematic review

Mesh:

Year:  2020        PMID: 33068239     DOI: 10.1007/s11136-020-02665-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  5 in total

1.  Psychosocial group intervention for patients with primary breast cancer: a randomised trial.

Authors:  Ellen H Boesen; Randi Karlsen; Jane Christensen; Birgitte Paaschburg; Dorte Nielsen; Iben Seier Bloch; Birgitte Christiansen; Kathrine Jacobsen; Christoffer Johansen
Journal:  Eur J Cancer       Date:  2011-03-31       Impact factor: 9.162

2.  Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis.

Authors:  Motahare Pilevarzadeh; Mehrbanoo Amirshahi; Roghaiyeh Afsargharehbagh; Hosein Rafiemanesh; Seyed-Mehdi Hashemi; Abbas Balouchi
Journal:  Breast Cancer Res Treat       Date:  2019-05-13       Impact factor: 4.872

3.  Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer.

Authors:  Oxana Palesh; Luke Peppone; Pasquale F Innominato; Michelle Janelsins; Monica Jeong; Lisa Sprod; Josee Savard; Max Rotatori; Shelli Kesler; Melinda Telli; Karen Mustian
Journal:  Nat Sci Sleep       Date:  2012-12-17

4.  Basic issues concerning health-related quality of life.

Authors:  Roman Sosnowski; Marta Kulpa; Urszula Ziętalewicz; Jan Karol Wolski; Robert Nowakowski; Robert Bakuła; Tomasz Demkow
Journal:  Cent European J Urol       Date:  2017-04-13

5.  Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial.

Authors:  Huihua Qiu; Wenwei Ren; Yanjie Yang; Xiongzhao Zhu; Guangyun Mao; Shanping Mao; Yan Lin; Shanshan Shen; Changjin Li; Hongying Shi; Suo Jiang; Jingjing He; Ke Zhao; Ye Fu; Xiaoqu Hu; Yingying Gu; Kai Wang; Xiuchan Guo; Jincai He
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-10       Impact factor: 2.570

  5 in total
  6 in total

1.  Comparison of the anxiety, depression and their relationship to quality of life among adult acute leukemia patients and their family caregivers: a cross-sectional study in China.

Authors:  Ying Wang; Jie Yan; JingYi Chen; ChunFeng Wang; YingChun Lin; Yong Wu; Rong Hu
Journal:  Qual Life Res       Date:  2021-02-17       Impact factor: 4.147

Review 2.  For whom and what outcomes does cognitive-behavioral-therapy work among cancer survivors: a systematic review and meta-analysis.

Authors:  Anao Zhang; Kaipeng Wang; Kate Blumenstein; Anna Brose; Chris Kemp; Dalton Meister; Phyllis Solomon
Journal:  Support Care Cancer       Date:  2022-08-30       Impact factor: 3.359

Review 3.  Development of a Framework for the Implementation of Synchronous Digital Mental Health: Realist Synthesis of Systematic Reviews.

Authors:  David Villarreal-Zegarra; Christoper A Alarcon-Ruiz; G J Melendez-Torres; Roberto Torres-Puente; Alba Navarro-Flores; Victoria Cavero; Juan Ambrosio-Melgarejo; Jefferson Rojas-Vargas; Guillermo Almeida; Leonardo Albitres-Flores; Alejandra B Romero-Cabrera; Jeff Huarcaya-Victoria
Journal:  JMIR Ment Health       Date:  2022-03-29

Review 4.  Psychological Aspects of Care in Cancer Patients in the Last Weeks/Days of Life.

Authors:  Sujin Ann-Yi; Eduardo Bruera
Journal:  Cancer Res Treat       Date:  2022-06-28       Impact factor: 5.036

5.  Quality of Life and Mental Health Status Among Cancer Patients With Metastatic Spinal Disease.

Authors:  Yaosheng Liu; Xuyong Cao; Xiongwei Zhao; Xiaolin Shi; Mingxing Lei; Haifeng Qin
Journal:  Front Public Health       Date:  2022-07-05

6.  Study Protocol of CBT-AP Trial: A Randomized Controlled Trial of Cognitive Behavioral Therapy Integrated with Activity Pacing for Fatigued Breast Cancer Patients Undergoing Chemotherapy.

Authors:  Mikiyas Amare Getu; Changying Chen; Panpan Wang; Elleni Yohannes; Edom Seife; Cui Panpan
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.